What is PathologyWatch?
PathologyWatch is a prominent provider of digital dermatopathology solutions, dedicated to enhancing workflow management, fostering collaboration, and optimizing patient outcomes for dermatology practices. The company's comprehensive service offerings include advanced test result delivery, seamless connectivity solutions, clinician education programs, and digital display options. PathologyWatch primarily serves dermatology practices and clinicians aiming to elevate their operational efficiency and patient care standards. Additionally, the company provides valuable resources to empower patients with information and support regarding their dermatological health.
How much funding has PathologyWatch raised?
PathologyWatch has raised a total of $34.3M across 4 funding rounds:
Unspecified
$2.3M
Series A
$5M
Unspecified
$2M
Series B
$25M
Unspecified (2019): $2.3M, investors not publicly disclosed
Series A (2020): $5M led by SpringTide Investments and Rock Creek Capital
Unspecified (2020): $2M supported by BioVentures Inc, Lateral Capital, Neue Fund, BeniVC, and Sky Ventures Group
Series B (2021): $25M featuring Ceros Capital Markets, Rock Creek Capital, SpringTide, and Spark Growth Ventures
Key Investors in PathologyWatch
Ceros Capital Markets
Ceros Capital Markets is a global investing platform specializing in fundraising for MedTech and Biotech companies, focusing on disruptive technologies in medical devices, robotics, and digital health. The firm primarily raises funds through Series A-D rounds for innovative companies developing non-invasive diagnostic procedures.
Rock Creek Capital
Rock Creek Capital is a company operating in the Venture Capital & Private Equity industry, headquartered in Jacksonville, Florida. They focus on investing in companies within this sector.
Spark Growth Ventures
Spark Growth Ventures is a community-driven venture capital firm based in San Diego, California, dedicated to supporting mid-stage technology startups globally. They emphasize collaboration among founders, investors, and industry experts to foster innovation and growth.
What's next for PathologyWatch?
With the recent influx of major strategic investment, PathologyWatch is poised for accelerated growth and market penetration. The company's focus on digital transformation within dermatopathology positions it favorably to capitalize on the increasing demand for efficient, collaborative, and patient-centric healthcare solutions. Future endeavors will likely involve expanding its service portfolio, enhancing its technological infrastructure, and broadening its reach to serve a larger segment of the dermatology market. This strategic financing will empower PathologyWatch to further solidify its leadership in the digital health space, driving innovation and improving the delivery of dermatological care.
See full PathologyWatch company page
